Bortezomib in Treating Patients With Multiple Myeloma Who Have Undergone an Autologous Peripheral Blood Stem Cell Transplant
Clinical trial NCT00288028 · COMPLETED
Trial details
- NCT number
- NCT00288028
- Sponsor
- Barbara Ann Karmanos Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-07-01
- Primary completion
- 2010-11-01
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.